Dr. Frazer is an internationally renowned leader in the field of genome biology and medicine. She is the director of UC San Diego Institute for Genomic Medicine and founding chief of the Division of Genome Information Sciences in the Department of Pediatrics at UC San Diego.
Matt Davis PhD joined Gritstone Oncology (NASDAQ: GRTS) in 2015 and is currently the Director of Molecular Biology and Sequencing responsible for various neo-antigen discovery and translational genomics efforts. Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group. He holds a PhD in Genetics from Yale with thesis research under the supervision of Dr. Joseph Schlessinger and previous to his graduate work he conducted cancer genomics research at Dana Farber Cancer Institute and the Broad Institute.
Miten is an Assistant Research Scientist at the University of California Santa Cruz. He did his PhD in Biomolecular Engineering and Bioinformatics at UC Santa Cruz in the nanopore group. His prior work and research interests include developing biological methods and software for: 1) analyzing genomics data; 2) long read sequencing of DNA and RNA; 3) resolving homopolymers and base modifications; 4) the nanopore MinION and PromethION sequencing platforms; and 5) sequencing and analysis of different classes of RNA (mRNA, rRNA, tRNA, non-coding RNA). His long term interests include combining sequence and structure information from DNA (genomics), RNA (coding and non-coding), and proteins, to better understand genome organization and function.
Matt Davis PhD joined Gritstone Oncology (NASDAQ: GRTS) in 2015 and is currently the Director of Molecular Biology and Sequencing responsible for various neo-antigen discovery and translational genomics efforts. Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group. He holds a PhD in Genetics from Yale with thesis research under the supervision of Dr. Joseph Schlessinger and previous to his graduate work he conducted cancer genomics research at Dana Farber Cancer Institute and the Broad Institute.
Miten is an Assistant Research Scientist at the University of California Santa Cruz. He did his PhD in Biomolecular Engineering and Bioinformatics at UC Santa Cruz in the nanopore group. His prior work and research interests include developing biological methods and software for: 1) analyzing genomics data; 2) long read sequencing of DNA and RNA; 3) resolving homopolymers and base modifications; 4) the nanopore MinION and PromethION sequencing platforms; and 5) sequencing and analysis of different classes of RNA (mRNA, rRNA, tRNA, non-coding RNA). His long term interests include combining sequence and structure information from DNA (genomics), RNA (coding and non-coding), and proteins, to better understand genome organization and function.
Matteo D’Antonio is an assistant project scientist in Kelly Frazer’s lab at UCSD, where is main focus is identifying the molecular mechanisms underlying the associations between genetic variation and disease. He got his Bachelor’s degree in biomedical engineering at Politecnico di Milano in Italy and his Master’s in Bioinformatics at the Technical University of Denmark. After that, he obtained his PhD at the European Institute of Oncology, where he studied the evolution of protein interaction networks and cancer genes. He joined UCSD in 2013 where he transitioned from cancer genomics to human genetics.
I am a Research Assistant Scientist at the University of Florida in the College of Medicine. My research interests revolve around molecular evolution and epidemiology of infectious diseases both within and among hosts, with a focus in phyloanatomy, sociovirology, and transmission cluster dynamics. The goal of my research is to identify relationships among genetic sequence data that can inform us as to the driving factors of pathogen evolution, interaction, and spread using state-of-the-art sequencing approaches and technology.
Mr. Arun Devotta is an Associate Research Scientist in the lab of Jean-Pierre Saint-Jeannet. Arun has a Masters in Biomedical Engineering from Polytechnic Institute of NYU. His research interests include developmental Biology, genetics and cell signaling. He is currently studying the signaling pathways regulating neural crest and cranial placode progenitors specification in Xenopus, two embryonic cell populations which form most of the craniofacial skeleton and sensory organs, respectively. When he is not in the lab, he’s probably enjoying an espresso in room 1007S.
Joshua Campbell received his Ph.D. in Bioinformatics from Boston University. He performed his postdoctoral research at Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT where he worked with The Cancer Genome Atlas (TCGA) to identify novel mutational drivers of lung cancer. He is currently an assistant professor in the Department of Medicine at Boston University School of Medicine where he develops novel Bayesian approaches to analyze data from single-cell genomic technologies to analyze cellular heterogeneity in lung and prostate cancer.
Santhoshi N Krishnan is a 5th-year doctoral student in the Department of Electrical and Computer Engineering at Rice University. She also holds a joint position as a Visiting Research Scholar at the Department of Computational Medicine and Bioinformatics at the University of Michigan, working under Dr. Arvind Rao. Her research interests lie in leveraging machine learning and spatial statistical methods to develop robust frameworks that characterize the disease microenvironment, with a special focus on cancer biology. Through her projects, she has been able to establish strong collaborative research relationships with healthcare providers, statisticians, and epidemiologists, with the aim of developing solutions that are in tune with real-world problems.
She holds a master’s degree in Bioengineering from Rice University, where she worked on quantifying the difference in treatment models in nuclear medicine. When not working, she enjoys reading science fiction books, baking, and plans to visit and hike through all the national parks in the Midwest region during her stay there.
Yu-Hwa Lo came to the Jacobs School in July of 1999. He has established a new lab to investigate biologically inspired photonic systems. A member of the Materials and Device Layer for the California Institute of Technology and Telecommuncations, he is collaborating with Professors Andy Kummel and William Trogler (Chemistry and Biochemistry) on early-warning biosensors. He is responsible for designing infrared photon counters in a joint effort with IBM's Almaden Research Center to build a quantum-communications system. He was Associate Professor of electrical engineering at Cornell University, prior to coming to UCSD. He received his Ph.D. from UC Berkeley in electrical engineering in 1987.
Dr. Rao works at the intersection of genomics and image informatics, across biological scale (cells, tissue and organ). He is interested in developing multi-modal decision algorithms that link and integrate various measurements (imaging, genomics etc) to characterize disease. His algorithms for phenotypic measurements encompass data from 2D/3D microscopy, radiology and histopathology. He is also interested in methodological aspects of genomic analysis and image assessment. In the context of these investigations, Dr. Rao collaborates with clinicians, biologists, engineers and data scientists.
Vanya Gant is an academic clinician with a PhD in Cellular Immunology. He is qualified in Microbiology and Infectious Diseases and Divisional Clinical Director for Infection at UCLH, having also led UCLH Pathology for several years and contributed to the core concepts, values and delivery of HSL.
He leads the Clinical infection service for UCLH’s large haematological malignancy Division and innovates and drives several strategic development projects for UCLH Trust.
He co-authored a book on Artificial Neural Networks in Clinical Medicine, was Principal Clinical Investigator for a novel “sample in/answer out” bacterial/viral detection platform currently undergoing EU accreditation and is Co-Principal Investigator for an innovative NIHR Programme grant on antimicrobial resistance. He has a keen interest in industry pull through from Academic innovation and advises the UK’s Technology Strategy Board (now Innovate UK) and several large academic research consortia in the UK and abroad. He founded and directs two Infection Management companies.
He is particularly proud of contributing to the development of the UK’s Find and Treat service, a unique mix of mobile diagnostics and innovative healthcare delivery for the UK’s poorest, and of being a Trustee for the Pathway Charity for the Homeless.
Ajay Nair’s research is focused on developing computational techniques to identify cellular regulatory interactions from high-throughput data. He completed his engineering master’s degree from IIT-Delhi holding first rank and Joint-PhD in Computational Biology from IIT-Bombay and Monash University, Australia. His postdoc training was with Prof. Andrea Califano and Prof. Robert Schwabe at Columbia University. Ajay and his team have identified regulatory interaction and identified drugs in Ovarian cancer and gastric cancer as well as identified and characterized disease causing fibroblasts in COVID-19 affected lungs, human ICC and liver metastases.
Francois received his PhD in 2012 in the field of molecular and cellular biology. He developed is skills in genetics during 5 years in a NGO dedicated to genetic therapy for rare diseases, focusing on RNA surgery. He then moved to a startup company developing High Content and Hight Throughput Screening cell-based assays. He did setup several models, focusing on skin and spheroids, and participated to the creation of a service platforms to give access to those models to the scientific community. Since early 2017, Francois joined Cellenion to lead developments related to single cell isolation applications. His team focus on the optimization of cell sorting and isolation process, as well as building disruptive approaches to analyses cells on any OMIC level. Its objective today is to give awareness and constantly improve those tools.
